A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
NKTR has a strong patent position on pegylation technology. They provide both the reagents and service based research technology for pegylation of biologics and small molecules. They are also one of the only companies in the US where GMP peg materials can be purchased.
Devistating blow by partner Pfizer with Exubra, but Nektar still retains the rights and will have to search hard to find another partner. Eventually, this product will catch on. This technology will advance and Nektar has made an important first step to advance inhalable therapeutics.